MeSH tree: D03.383
DNA methylation patterns present at diagnosis could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine. That's the key finding of a new multicenter study involving researchers at ...
7 hours ago
0
2
Adults with heart or blood vessel disease who started treatment with a statin alone had rates of heart attack, stroke and other heart problems over three years similar to those who started with a statin plus ezetimibe (a ...
21 hours ago
0
6
Among older adults with high blood pressure and atrial fibrillation, treatment with a combination of two blood pressure medications was associated with fewer recurring irregular heart rhythms after an ablation procedure compared ...
22 hours ago
0
37
Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths. ...
Nov 6, 2026
0
11
A blocked nose can make it difficult to sleep and taste food, and it can get really annoying after a while. Nasal decongestant sprays like oxymetazoline can provide relief, but continued use can worsen nasal obstruction by ...
Atherosclerosis is a condition in which cholesterol and fat gradually accumulate inside the walls of medium and large arteries, forming a sticky deposit called plaque. As these deposits grow, they narrow the arteries, restricting ...
A natural plant compound may help overcome a built-in defense that allows many cancers to resist a class of drugs designed to restore normal gene activity, according to a study by researchers at the Johns Hopkins Sidney Kimmel ...
Nov 2, 2026
0
104
Researchers at the University of Chicago have identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them. The study, published in Cancer Cell, shows that radiation ...
Oct 31, 2026
0
101
Researchers at the University of Tsukuba conducted a physician-initiated phase 2 clinical trial of dasatinib in patients with relapsed or refractory T-follicular helper cell lymphoma (TFHL), an aggressive and difficult-to-treat ...
Oct 29, 2026
0
8
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
